115 results on '"Jung, Su Yon"'
Search Results
2. Preprocedural Video Education on Liver Ablation Treatment
- Author
-
Anuran-Torres, Jhoanna, Cardin, Suzette, Grimley, Karen, Jung, Su Yon, Kim-Saechao, Sue, and Clark, Lauren
- Published
- 2024
- Full Text
- View/download PDF
3. DNA methylation in peripheral blood leukocytes for the association with glucose metabolism and invasive breast cancer
- Author
-
Jung, Su Yon, Bhatti, Parveen, and Pellegrini, Matteo
- Published
- 2023
- Full Text
- View/download PDF
4. Estimating heritability explained by local ancestry and evaluating stratification bias in admixture mapping from summary statistics
- Author
-
Chan, Tsz Fung, Rui, Xinyue, Conti, David V., Fornage, Myriam, Graff, Mariaelisa, Haessler, Jeffrey, Haiman, Christopher, Highland, Heather M., Jung, Su Yon, Kenny, Eimear E., Kooperberg, Charles, Le Marchand, Loic, North, Kari E., Tao, Ran, Wojcik, Genevieve, Gignoux, Christopher R., Chiang, Charleston W.K., and Mancuso, Nicholas
- Published
- 2023
- Full Text
- View/download PDF
5. Biomarkers of glucose homeostasis as mediators of the relationship of body mass index and waist circumference with COVID-19 outcomes among postmenopausal women: The Women’s Health Initiative
- Author
-
Beydoun, Hind A., Ng, Ted K.S., Beydoun, May A., Shadyab, Aladdin H., Jung, Su Yon, Costanian, Christy, Saquib, Nazmus, Ikramuddin, Farha S., Pan, Kathy, Zonderman, Alan B., and Manson, JoAnn E.
- Published
- 2023
- Full Text
- View/download PDF
6. Birth weight, adult body size, and risk of colorectal cancer
- Author
-
Su, Le, Hendryx, Michael, Li, Ming, Pichardo, Margaret S., Jung, Su Yon, Lane, Dorothy S., Chlebowski, Rowan, Sun, Yangbo, Li, Chao, and Luo, Juhua
- Published
- 2023
- Full Text
- View/download PDF
7. Genetic pleiotropy underpinning adiposity and inflammation in self-identified Hispanic/Latino populations
- Author
-
Anwar, Mohammad Yaser, Baldassari, Antoine R., Polikowsky, Hannah G., Sitlani, Colleen M., Highland, Heather M., Chami, Nathalie, Chen, Hung-Hsin, Graff, Mariaelisa, Howard, Annie Green, Jung, Su Yon, Petty, Lauren E., Wang, Zhe, Zhu, Wanying, Buyske, Steven, Cheng, Iona, Kaplan, Robert, Kooperberg, Charles, Loos, Ruth J. F., Peters, Ulrike, McCormick, Joseph B., Fisher-Hoch, Susan P., Avery, Christy L., Taylor, Kira C., Below, Jennifer E., and North, Kari E.
- Published
- 2022
- Full Text
- View/download PDF
8. Diabetes risk reduction diet and risk of liver cancer and chronic liver disease mortality: A prospective cohort study.
- Author
-
Chen, Yun, Zhao, Longgang, Jung, Su Yon, Pichardo, Margaret S., Lopez‐Pentecost, Melissa, Rohan, Thomas E., Saquib, Nazmus, Sun, Yangbo, Tabung, Fred K., Zheng, Tongzhang, Wactawski‐Wende, Jean, Manson, JoAnn E., Neuhouser, Marian L, and Zhang, Xuehong
- Subjects
PROPORTIONAL hazards models ,UNSATURATED fatty acids ,LIVER cancer ,GLYCEMIC index ,LIVER diseases - Abstract
Background: We aimed to prospectively evaluate the association between a diabetes risk reduction diet (DRRD) score and the risk of liver cancer development and chronic liver disease‐specific mortality. Methods: We included 98,786 postmenopausal women from the Women's Health Initiative‐Observational Study and the usual diet arm of the Diet Modification trial. The DRRD score was derived from eight factors: high intakes of dietary fiber, coffee, nuts, polyunsaturated fatty acids, low intakes of red and processed meat, foods with high glycemic index, sugar‐sweetened beverages (SSBs), and trans fat based on a validated Food‐Frequency Questionnaire administered at baseline (1993–1998). Multivariable hazard ratios (HRs) and 95% confidence intervals (CIs) for liver cancer incidence and chronic liver disease mortality were estimated using Cox proportional hazards regression models. Results and conclusion: After a median follow‐up of 22.0 years, 216 incident liver cancer cases and 153 chronic liver disease deaths were confirmed. A higher DRRD score was significantly associated with a reduced risk of developing liver cancer (HRTertile 3 vs. Tertile 1 = 0.69; 95% CI: 0.49–0.97; Ptrend = 0.03) and chronic liver disease mortality (HRT3 vs. T1 = 0.54; 95% CI: 0.35–0.82; Ptrend = 0.003). We further found inverse associations with dietary fiber and coffee, and positive associations with dietary glycemic index, SSBs, and trans fat. A higher DRRD score was associated with reduced risk of developing liver cancer and chronic liver disease mortality among postmenopausal women. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. Low physical function following cancer diagnosis is associated with higher mortality risk in postmenopausal women.
- Author
-
Gonzalo-Encabo, Paola, Vasbinder, Alexi, Bea, Jennifer W, Reding, Kerryn W, Laddu, Deepika, LaMonte, Michael J, Stefanick, Marcia L, Kroenke, Candyce H, Jung, Su Yon, Shadyab, Aladdin H, Naughton, Michelle J, Patel, Manali I, Luo, Juhua, Banack, Hailey R, Sun, Yangbo, Simon, Michael S, and Dieli-Conwright, Christina M
- Subjects
PHYSICAL mobility ,POSTMENOPAUSE ,CANCER diagnosis ,CANCER-related mortality ,WOMEN'S health - Abstract
Background Postmenopausal women with cancer experience an accelerated physical dysfunction beyond what is expected through aging alone due to cancer and its treatments. The aim of this study was to determine whether declines in physical function after cancer diagnosis are associated with all-cause mortality and cancer-specific mortality. Methods This prospective cohort study included 8068 postmenopausal women enrolled in the Women's Health Initiative with a cancer diagnosis and who had physical function assessed within 1 year of that diagnosis. Self-reported physical function was measured using the 10-item physical function subscale of the 36-Item Short Form Health Survey. Cause of death was determined by medical record review, with central adjudication and linkage to the National Death Index. Death was adjudicated through February 2022. Results Over a median follow-up of 7.7 years from cancer diagnosis, 3316 (41.1%) women died. Our results showed that for every 10% difference in the physical function score after cancer diagnosis versus pre-diagnosis, all-cause mortality and cancer-specific mortality were reduced by 12% (hazard ratio [HR] = 0.88, 95% confidence interval [95% CI] = 0.87 to 0.89 and HR = 0.88, 95% CI = 0.86 to 0.91, respectively). Further categorical analyses showed a significant dose-response relationship between postdiagnosis physical function categories and mortality outcomes (P < .001 for trend), where the median survival time for women in the lowest physical function quartile was 9.1 years (Interquartile range [IQR] = 8.6-10.6 years) compared with 18.4 years (IQR = 15.8-22.0 years) for women in the highest physical function quartile. Conclusion Postmenopausal women with low physical function after cancer diagnosis may be at higher risk of mortality from all causes and cancer-related mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Pro-inflammatory cytokine polymorphisms and interactions with dietary alcohol and estrogen, risk factors for invasive breast cancer using a post genome-wide analysis for gene–gene and gene–lifestyle interaction
- Author
-
Jung, Su Yon, Papp, Jeanette C., Sobel, Eric M., Pellegrini, Matteo, Yu, Herbert, and Zhang, Zuo-Feng
- Published
- 2021
- Full Text
- View/download PDF
11. Genetic Signatures of Glucose Homeostasis: Synergistic Interplay With Long-Term Exposure to Cigarette Smoking in Development of Primary Colorectal Cancer Among African American Women
- Author
-
Jung, Su Yon
- Published
- 2021
- Full Text
- View/download PDF
12. The effects of genetic variants related to insulin metabolism pathways and the interactions with lifestyles on colorectal cancer risk
- Author
-
Jung, Su Yon and Zhang, Zuo-Feng
- Published
- 2019
- Full Text
- View/download PDF
13. Interaction of insulin-like growth factor-I and insulin resistance-related genetic variants with lifestyle factors on postmenopausal breast cancer risk
- Author
-
Jung, Su Yon, Ho, Gloria, Rohan, Thomas, Strickler, Howard, Bea, Jennifer, Papp, Jeanette, Sobel, Eric, Zhang, Zuo-Feng, and Crandall, Carolyn
- Published
- 2017
- Full Text
- View/download PDF
14. Associations between time spent sitting and cancer-related biomarkers in postmenopausal women: an exploration of effect modifiers
- Author
-
Paxton, Raheem J., Jung, Su Yon, Vitolins, Mara Z., Fenton, Jenifer, Paskett, Electra, Pollak, Michael, Hays-Grudo, Jennifer, Hursting, Stephen D., and Chang, Shine
- Published
- 2014
15. Opium, phencyclidine, and crack cocaine smoking associations with lung and upper aerodigestive tract cancers: exploratory findings from a case-control study in Los Angeles County.
- Author
-
Zhang, Mingyan, Hashibe, Mia, Rao, Jian-Yu, Jung, Su Yon, Tashkin, Donald P., Morgenstern, Hal, and Zhang, Zuo-Feng
- Subjects
CRACK cocaine ,DRUG abuse ,PHENCYCLIDINE ,SMOKING ,OPIUM - Abstract
Background: Illicit drug use has become a global epidemic, yet it is unclear if drug smoking increases the risk of tobacco-related cancers. Objectives: We aimed to evaluate hypothesized associations between smoking three drugs – opium, phencyclidine (PCP) and crack cocaine and lung and upper aerodigestive tract (UADT) cancers. Methods: A population-based case-control study with 611 lung cancer cases (50% male), 601 UADT cancers cases (76% male), and 1,040 controls (60% male) was conducted in Los Angeles County (1999–2004). Epidemiologic data including drug smoking histories were collected in face-to-face interviews. Associations were estimated with logistic regressions. Results: Adjusting for potential confounders, ever vs. never crack smoking was positively associated with UADT cancers (aOR = 1.56, 95% CI: 1.05, 2.33), and a dose-response relationship was observed for lifetime smoking frequency (p for trend =.024). Heavy (> median) vs. never crack smoking was associated with UADT cancers (aOR = 1.81, 95% CI: 1.07, 3.08) and lung cancer (aOR = 1.58, 95% CI: 0.88, 2.83). A positive association was also observed between heavy PCP smoking and UADT cancers (aOR = 2.29, 95% CI: 0.91, 5.79). Little or no associations were found between opium smoking and lung cancer or UADT cancers. Conclusion: The positive associations between illicit drug use and lung and/or UADT cancers suggest that smoking these drugs may increase the risk of tobacco-related cancers. Despite the low frequency of drug smoking and possible residual confounding, our findings may provide additional insights on the development of lung and UADT cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women
- Author
-
Jung, Su Yon, Barrington, Wendy E., Lane, Dorothy S., Chen, Chu, Chlebowski, Rowan, Corbie-Smith, Giselle, Hou, Lifang, Zhang, Zuo-Feng, Paek, Min-So, and Crandall, Carolyn J.
- Published
- 2017
- Full Text
- View/download PDF
17. Factors associated with mortality after breast cancer metastasis
- Author
-
Jung, Su Yon, Rosenzweig, Margaret, Sereika, Susan M., Linkov, Faina, Brufsky, Adam, and Weissfeld, Joel L.
- Published
- 2012
18. Exogenous Estrogen as Mediator of Racial Differences in Bioactive Insulin-Like Growth Factor-I Levels Among Postmenopausal Women
- Author
-
Jung, Su Yon, Vitolins, Mara Z., Paskett, Electra D., and Chang, Shine
- Published
- 2015
- Full Text
- View/download PDF
19. The effect of delays in treatment for breast cancer metastasis on survival
- Author
-
Jung, Su Yon, Sereika, Susan M., Linkov, Faina, Brufsky, Adam, Weissfeld, Joel L., and Rosenzweig, Margaret
- Published
- 2011
- Full Text
- View/download PDF
20. Contagious Diseases in the United States from 1888 to the Present
- Author
-
van Panhuis, Willem G., Grefenstette, John, Jung, Su Yon, Chok, Nian Shong, Cross, Anne, Eng, Heather, Lee, Bruce Y., Zadorozhny, Vladimir, Brown, Shawn, Cummings, Derek, and Burke, Donald S.
- Published
- 2013
- Full Text
- View/download PDF
21. Synergistic Effects of Genetic Variants of Glucose Homeostasis and Lifelong Exposures to Cigarette Smoking, Female Hormones, and Dietary Fat Intake on Primary Colorectal Cancer Development in African and Hispanic/Latino American Women.
- Author
-
Jung, Su Yon, Sobel, Eric M., Pellegrini, Matteo, Yu, Herbert, and Papp, Jeanette C.
- Subjects
COLORECTAL cancer ,HISPANIC Americans ,GENETIC variation ,FOOD consumption ,CARCINOGENESIS ,SMOKING statistics ,HIGH-carbohydrate diet - Abstract
Background: Disparities in cancer genomic science exist among racial/ethnic minorities. Particularly, African American (AA) and Hispanic/Latino American (HA) women, the 2 largest minorities, are underrepresented in genetic/genome-wide studies for cancers and their risk factors. We conducted on AA and HA postmenopausal women a genomic study for insulin resistance (IR), the main biologic mechanism underlying colorectal cancer (CRC) carcinogenesis owing to obesity. Methods: With 780 genome-wide IR-specific single-nucleotide polymorphisms (SNPs) among 4,692 AA and 1,986 HA women, we constructed a CRC-risk prediction model. Along with these SNPs, we incorporated CRC-associated lifestyles in the model of each group and detected the topmost influential genetic and lifestyle factors. Further, we estimated the attributable risk of the topmost risk factors shared by the groups to explore potential factors that differentiate CRC risk between these groups. Results: In both groups, we detected IR-SNPs in PCSK1 (in AA) and IFT172 , GCKR , and NRBP1 (in HA) and risk lifestyles, including long lifetime exposures to cigarette smoking and endogenous female hormones and daily intake of polyunsaturated fatty acids (PFA), as the topmost predictive variables for CRC risk. Combinations of those top genetic- and lifestyle-markers synergistically increased CRC risk. Of those risk factors, dietary PFA intake and long lifetime exposure to female hormones may play a key role in mediating racial disparity of CRC incidence between AA and HA women. Conclusions: Our results may improve CRC risk prediction performance in those medically/scientifically underrepresented groups and lead to the development of genetically informed interventions for cancer prevention and therapeutic effort, thus contributing to reduced cancer disparities in those minority subpopulations. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
22. Interactions Between Adiponectin-Pathway Polymorphisms and Obesity on Postmenopausal Breast Cancer Risk Among African American Women: The WHI SHARe Study.
- Author
-
Nam, Gina E., Zhang, Zuo-Feng, Rao, Jianyu, Zhou, Hua, and Jung, Su Yon
- Subjects
DISEASE risk factors ,AFRICAN American women ,BREAST cancer ,GENOME-wide association studies ,GENETIC variation ,GENOTYPE-environment interaction - Abstract
Background: A decreased level of serum adiponectin is associated with obesity and an increased risk of breast cancer among postmenopausal women. Yet, the interplay between genetic variants associated with adiponectin phenotype, obesity, and breast cancer risk is unclear in African American (AA) women. Methods: We examined 32 single-nucleotide polymorphisms (SNPs) previously identified in genome-wide association and replication studies of serum adiponectin levels using data from 7,991 AA postmenopausal women in the Women's Health Initiative SNP Health Association Resource. Results: Stratifying by obesity status, we identified 18 adiponectin-related SNPs that were associated with breast cancer risk. Among women with BMI ≥ 30 kg/m
2 , the minor TT genotype of FER rs10447248 had an elevated breast cancer risk. Interaction was observed between obesity and the CT genotype of ADIPOQ rs6773957 on the additive scale for breast cancer risk (relative excess risk due to interaction, 0.62; 95% CI, 0.32–0.92). The joint effect of BMI ≥ 30 kg/m2 and the TC genotype of OR8S1 rs11168618 was larger than the sum of the independent effects on breast cancer risk. Conclusions: We demonstrated that obesity plays a significant role as an effect modifier in an increased effect of the SNPs on breast cancer risk using one of the most extensive data on postmenopausal AA women. Impact: The results suggest the potential use of adiponectin genetic variants as obesity-associated biomarkers for informing AA women who are at greater risk for breast cancer and also for promoting behavioral interventions, such as weight control, to those with risk genotypes. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
23. Genetically Predicted C-Reactive Protein Associated With Postmenopausal Breast Cancer Risk: Interrelation With Estrogen and Cancer Molecular Subtypes Using Mendelian Randomization.
- Author
-
Jung, Su Yon, Papp, Jeanette C., Sobel, Eric M., Pellegrini, Matteo, Yu, Herbert, and Zhang, Zuo-Feng
- Subjects
HORMONE receptor positive breast cancer ,C-reactive protein ,BREAST cancer ,EPIDERMAL growth factor ,SINGLE nucleotide polymorphisms ,GENOTYPE-environment interaction - Abstract
Background: Immune-related etiologic pathways that influence breast cancer risk are incompletely understood and may be confounded by lifestyles or reverse causality. Using a Mendelian randomization (MR) approach, we investigated the potential causal relationship between genetically elevated C-reactive protein (CRP) concentrations and primary invasive breast cancer risk in postmenopausal women. Methods: We used individual-level data obtained from 10,179 women, including 537 who developed breast cancer, from the Women's Health Initiative Database for Genotypes and Phenotypes Study, which consists of five genome-wide association (GWA) studies. We examined 61 GWA single-nucleotide polymorphisms (SNPs) previously associated with CRP. We employed weighted/penalized weighted–medians and MR gene–environment interactions that allow instruments' invalidity to some extent and attenuate the heterogeneous estimates of outlying SNPs. Results: In lifestyle-stratification analyses, genetically elevated CRP decreased risk for breast cancer in exogenous estrogen-only, estrogen + progestin, and past oral contraceptive (OC) users, but only among relatively short-term users (<5 years). Estrogen-only users for ≥5 years had more profound CRP-decreased breast cancer risk in dose–response fashion, whereas past OC users for ≥5 years had CRP-increased cancer risk. Also, genetically predicted CRP was strongly associated with increased risk for hormone-receptor positive or human epidermal growth factor receptor-2 negative breast cancer. Conclusions: Our findings may provide novel evidence on the immune-related molecular pathways linking to breast cancer risk and suggest potential clinical use of CRP to predict the specific cancer subtypes. Our findings suggest potential interventions targeting CRP–inflammatory markers to reduce breast cancer risk. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
24. The Role of Genetically Determined Glycemic Traits in Breast Cancer: A Mendelian Randomization Study.
- Author
-
Jung, Su Yon, Mancuso, Nicholas, Han, Sihao, and Zhang, Zuo-Feng
- Subjects
BREAST cancer ,SINGLE nucleotide polymorphisms ,GLUTATHIONE transferase - Abstract
Background: Circulating glycemic traits (GTs) have been considered a risk factor for breast cancer, but studies using GT-associated genetic variants as an instrumental variable are limited and inconclusive. Methods: Our Mendelian Randomization analysis used the most recent genome-wide datasets focusing on European women. Results: Of 44 single-nucleotide polymorphisms (SNPs) with GTs, 38 fasting-glucose and 6 fasting-insulin SNPs showed heterogeneous associations with breast cancer, without significant directional pleiotropy observed. Conclusion: Our findings indicate a null association between genetically determined GTs and breast cancer risk among European women. Our findings may contribute to more complete characterizing of metabolic pathways in GTs and breast cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
25. Family history of liver cancer may modify the association between HBV infection and liver cancer in a Chinese population.
- Author
-
Liu, Xing, Baecker, Aileen, Wu, Ming, Zhou, Jin‐Yi, Yang, Jie, Han, Ren‐Qiang, Wang, Pei‐Hua, Jin, Zi‐Yi, Liu, Ai‐Min, Gu, Xiaoping, Zhang, Xiao‐Feng, Wang, Xu‐Shan, Su, Ming, Hu, Xu, Sun, Zheng, Li, Gang, Fu, Alan, Jung, Su Yon, Mu, Lina, and He, Na
- Subjects
LIVER cancer - Abstract
Background & Aims: The potential interaction between family history of liver cancer and HBV infection on liver cancer has not been fully examined. Methods: We conducted a population‐based case‐control study composed of 2011 liver cancer cases and 7933 controls in Jiangsu province, China from 2003 to 2010. Data on major risk or protective factors were collected and HBV/HCV sero‐markers were assayed using blood samples. Semi‐Bayes (SB) adjustments were applied to provide posterior estimates. Results: Both family history of liver cancer (adjusted odds ratios [OR]: 4.32, 95% confidence intervals [CI]: 3.25‐5.73) and hepatitis B surface antigen (HBsAg) positivity (adjusted OR: 9.94, 95% CI: 8.33‐11.87) were strongly associated with liver cancer development. For individuals with different combinations of serological markers, the adjusted ORs were 8.45 (95% CI: 5.16‐13.82) for HBsAg‐ and HBcAb‐positive; 7.57 (95% CI: 4.87‐11.77) for HBsAg‐, HBeAg‐ and HBcAb‐positive; and 3.62 (95% CI: 2.47‐5.31) for HBsAg‐, HBeAb‐ and HBcAb‐positive, compared to all negatives in HBV serological markers. One log increase in HBV DNA level was associated with 17% increased risk (adjusted OR: 1.17, 95% CI: 1.03‐1.32). The SB‐adjusted OR of HBV‐positive individuals with family history of liver cancer was 41.34 (95% posterior interval [PI]: 23.69‐72.12) compared with those HBV‐negative without family history. Relative excess risk due to additive interaction, the attributable proportion and synergy index were 73.13, 0.87 and 8.04 respectively. Adjusted ratio of OR for multiplicative interaction was 2.84 (95% CI: 1.41‐5.75). Conclusions: Super‐additive and super‐multiplicative interactions may exist between family history of liver cancer and HBV infection on the development of liver cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
26. Post genome-wide gene-environment interaction study: The effect of genetically driven insulin resistance on breast cancer risk using Mendelian randomization.
- Author
-
Jung, Su Yon, Mancuso, Nicholas, Papp, Jeanette, Sobel, Eric, and Zhang, Zuo-Feng
- Subjects
- *
GENOTYPE-environment interaction , *BREAST cancer , *INSULIN resistance , *BODY mass index - Abstract
Purpose: The role of insulin resistance (IR) in developing postmenopausal breast cancer has not been thoroughly resolved and may be confounded by lifestyle factors such as obesity. We examined whether genetically determined IR is causally associated with breast cancer risk. Methods: We conducted Mendelian randomization (MR) analyses using individual-level data from our previous meta-analysis of a genome-wide association study (GWAS) (n = 11,109 non-Hispanic white postmenopausal women). Four single-nucleotide polymorphisms were associated with fasting glucose (FG), 2 with fasting insulin (FI), and 6 with homeostatic model assessment–IR (HOMA-IR) but were not associated with obesity. We used this GWAS to employ hazard ratios (HRs) for breast cancer risk by adjusting for potential confounding factors. Results: No direct association was observed between comprising 12 IR genetic instruments and breast cancer risk (HR = 0.93, 95% CI: 0.76–1.14). In phenotype-specific analysis, genetically elevated FG was associated with reduced risk for breast cancer (main contributor of this MR-effect estimate: G6PC2 rs13431652; HR = 0.59, 95% CI: 0.35–0.99). Genetically driven FI and HOMA-IR were not significantly associated. Stratification analyses by body mass index, exercise, and dietary fat intake with combined phenotypes showed that genetically elevated IR was associated with greater breast cancer risk in overall obesity and inactive subgroups (single contributor: MTRR/LOC729506 rs13188458; HR = 2.21, 95% CI: 1.03–4.75). Conclusions: We found complex evidence for causal association between IR and risk of breast cancer, which may support the potential value of intervention trials to lower IR and reduce breast cancer risk. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
27. Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
- Author
-
Jung, Su Yon, Rohan, Thomas, Strickler, Howard, Bea, Jennifer, Zhang, Zuo-Feng, Ho, Gloria, and Crandall, Carolyn
- Subjects
- *
INSULIN resistance , *COLON cancer , *POSTMENOPAUSE , *SINGLE nucleotide polymorphisms , *INSULIN , *ESTROGEN - Abstract
Genetic variants and traits in metabolic signaling pathways may interact with lifestyle factors such as obesity, physical activity, and exogenous estrogen (E), influencing postmenopausal colorectal cancer (CRC) risk, but these interrelated pathways are not fully understood. In this case-cohort study, we examined 33 single-nucleotide polymorphisms (SNPs) in genes related to insulin-like growth factor-I (IGF-I)/ insulin resistance (IR) traits and signaling pathways, using data from 704 postmenopausal women in Women’s Health Initiative Observation ancillary studies. Stratifying by the lifestyle modifiers, we assessed the effects of IGF-I/IR traits (fasting total and free IGF-I, IGF binding protein-3, insulin, glucose, and homeostatic model assessment–insulin resistance) on CRC risk as a mediator or influencing factor. Six SNPs in the INS, IGF-I, and IGFBP3 genes were associated with CRC risk, and those associations differed between non-obese/active and obese/inactive women and between E nonusers and users. Roughly 30% of the cancer risk due to the SNP was mediated by IGF-I/IR traits. Likewise, carriers of 11 SNPs in the IRS1 and AKT1/2 genes (signaling pathway–related genetic variants) had different associations with CRC risk between strata, and the proportion of the SNP–cancer association explained by traits varied from 30% to 50%. Our findings suggest that IGF-I/IR genetic variants interact with obesity, physical activity, and exogenous E, altering postmenopausal CRC risk, through IGF-I/IR traits, but also through different pathways. Unraveling gene–phenotype–lifestyle interactions will provide data on potential genetic targets in clinical trials for cancer prevention and intervention strategies to reduce CRC risk. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
28. Effect of genetic variants and traits related to glucose metabolism and their interaction with obesity on breast and colorectal cancer risk among postmenopausal women.
- Author
-
Su Yon Jung, Sobel, Eric M., Papp, Jeanette C., Zuo-Feng Zhang, Jung, Su Yon, and Zhang, Zuo-Feng
- Subjects
GLUCOSE metabolism ,OBESITY ,COLON cancer ,SINGLE nucleotide polymorphisms ,BREAST cancer ,BLOOD sugar ,BREAST tumors ,COLON tumors ,GENETIC polymorphisms ,INSULIN ,INSULIN resistance ,RECTUM tumors ,POSTMENOPAUSE ,SEQUENCE analysis - Abstract
Background: Impaired glucose metabolism-related genetic variants and traits likely interact with obesity and related lifestyle factors, influencing postmenopausal breast and colorectal cancer (CRC), but their interconnected pathways are not fully understood. By stratifying via obesity and lifestyles, we partitioned the total effect of glucose metabolism genetic variants on cancer risk into two putative mechanisms: 1) indirect (risk-associated glucose metabolism genetic variants mediated by glucose metabolism traits) and 2) direct (risk-associated glucose metabolism genetic variants through pathways other than glucose metabolism traits) effects.Method: Using 16 single-nucleotide polymorphisms (SNPs) associated with glucose metabolism and data from 5379 postmenopausal women in the Women's Health Initiative Harmonized and Imputed Genome-Wide Association Studies, we retrospectively assessed the indirect and direct effects of glucose metabolism-traits (fasting glucose, insulin, and homeostatic model assessment-insulin resistance [HOMA-IR]) using two quantitative tests.Results: Several SNPs were associated with breast cancer and CRC risk, and these SNP-cancer associations differed between non-obese and obese women. In both strata, the direct effect of cancer risk associated with the SNP accounted for the majority of the total effect for most SNPs, with roughly 10% of cancer risk due to the SNP that was from an indirect effect mediated by glucose metabolism traits. No apparent differences in the indirect (glucose metabolism-mediated) effects were seen between non-obese and obese women. It is notable that among obese women, 50% of cancer risk was mediated via glucose metabolism trait, owing to two SNPs: in breast cancer, in relation to GCKR through glucose, and in CRC, in relation to DGKB/TMEM195 through HOMA-IR.Conclusions: Our findings suggest that glucose metabolism genetic variants interact with obesity, resulting in altered cancer risk through pathways other than those mediated by glucose metabolism traits. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
29. Bioavailable insulin-like growth factor-I as mediator of racial disparity in obesity-relevant breast and colorectal cancer risk among postmenopausal women.
- Author
-
Su Yon Jung, Barrington, Wendy E., Lane, Dorothy S., Chu Chen, Chlebowski, Rowan, Corbie-Smith, Giselle, Lifang Hou, Zuo-Feng Zhang, Min-So Paek, Crandall, Carolyn J., Jung, Su Yon, Chen, Chu, Hou, Lifang, Zhang, Zuo-Feng, and Paek, Min-So
- Published
- 2017
- Full Text
- View/download PDF
30. Obesity and associated lifestyles modify the effect of glucose metabolism-related genetic variants on impaired glucose homeostasis among postmenopausal women.
- Author
-
Jung, Su Yon, Sobel, Eric M., Papp, Jeanette C., Crandall, Carolyn J., Fu, Alan N., and Zhang, Zuo‐Feng
- Published
- 2016
- Full Text
- View/download PDF
31. In cross-sectional observations, dietary quality is not associated with CVD risk in women; in men the positive association is accounted for by BMI.
- Author
-
Frazier-Wood, Alexis C., Kim, Jihye, Davis, Jennifer S., Jung, Su Yon, and Chang, Shine
- Subjects
CARDIOVASCULAR diseases risk factors ,DEMOGRAPHY ,DIET ,FOOD composition ,INGESTION ,INTERVIEWING ,NUTRITIONAL requirements ,PROBABILITY theory ,QUESTIONNAIRES ,RESEARCH funding ,SEX distribution ,SURVEYS ,T-test (Statistics) ,BODY mass index ,LIFESTYLES ,DATA analysis software - Abstract
The role that BMI plays in the association between dietary quality and CVD risk is not known. We aimed to better understand this relationship using statistical methods which correct for sex-specific underreporting of dietary intake. Overall, dietary quality was assessed using the Healthy Eating Index (HEI) on data from 9797 non-pregnant adults (aged >20 years) who participated in the National Health and Nutrition Examination Survey from 2005 to 2010. CVD risk factors included blood pressure, fasting glucose and insulin, homeostatic models of insulin resistance (HOMA-IR), HDL- and LDL-cholesterol (HDL-C and LDL-C), TAG and C-reactive protein (CRP). We controlled for demographic and lifestyle covariates, and we used the population ratio approach (which adjusts for the underreporting of intake) to compare mean HEI scores between the top and bottom quartiles of covariate-adjusted CVD risk factors. In women, the total HEI score was not associated with any CVD risk factors (all Q>0·11). In men, the total HEI score was associated with covariate-adjusted residuals for fasting insulin (Q< 0·001), HOMA-IR (Q< 0·001), HDL-C (Q= 0·01), TAG (Q= 0·03) and CRP (Q< 0·001). When we additionally adjusted for BMI, the association with total HEI score was not significant (all P>0·10). In the present analyses, dietary quality was associated with five CVD risk factors in a sex-specific manner. Moreover, the association of BMI with CVD risk attenuated the relationship between CVD risk and diet, which suggests that BMI is an important factor in heart disease prevention. [ABSTRACT FROM PUBLISHER]
- Published
- 2015
- Full Text
- View/download PDF
32. Risk Profiles for Weight Gain among Postmenopausal Women: A Classification and Regression Tree Analysis Approach.
- Author
-
Jung, Su Yon, Vitolins, Mara Z., Fenton, Jenifer, Frazier-Wood, Alexis C., Hursting, Stephen D., and Chang, Shine
- Subjects
- *
POSTMENOPAUSE , *WEIGHT gain , *OBESITY complications , *REGRESSION trees , *HEALTH outcome assessment - Abstract
Purpose: Risk factors for obesity and weight gain are typically evaluated individually while “adjusting for” the influence of other confounding factors, and few studies, if any, have created risk profiles by clustering risk factors. We identified subgroups of postmenopausal women homogeneous in their clustered modifiable and non-modifiable risk factors for gaining ≥ 3% weight. Methods: This study included 612 postmenopausal women 50–79 years old, enrolled in an ancillary study of the Women's Health Initiative Observational Study between February 1995 and July 1998. Classification and regression tree and stepwise regression models were built and compared. Results: Of 27 selected variables, the factors significantly related to ≥ 3% weight gain were weight change in the past 2 years, age at menopause, dietary fiber, fat, alcohol intake, and smoking. In women younger than 65 years, less than 4 kg weight change in the past 2 years sufficiently reduced risk of ≥ 3% weight gain. Different combinations of risk factors related to weight gain were reported for subgroups of women: women 65 years or older (essential factor: < 9.8 g/day dietary factor), African Americans (essential factor: currently smoking), and white women (essential factor: ≥ 5 kg weight change for the past 2 years). Conclusions: Our findings suggest specific characteristics for particular subgroups of postmenopausal women that may be useful for identifying those at risk for weight gain. The study results may be useful for targeting efforts to promote strategies to reduce the risk of obesity and weight gain in subgroups of postmenopausal women and maximize the effect of weight control by decreasing obesity-relevant adverse health outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
33. Comorbidity as a Mediator of Survival Disparity Between Younger and Older Women Diagnosed With Metastatic Breast Cancer.
- Author
-
Jung, Su Yon, Rosenzweig, Margaret, Linkov, Faina, Brufsky, Adam, Weissfeld, Joel L., and Sere, Susan M.
- Abstract
The article focuses on a study on the relationship between hypertension-augmented comorbidity and a prognosis for survival between younger and older women with metastatic breast cancer. It describes the methodology and the 2 approaches applied to compute the percentage change in the hazard ratios within the age-survival relationship. It recommends the inclusion of hypertension in the comorbidity information as part of decision-making support programs.
- Published
- 2012
- Full Text
- View/download PDF
34. Molecular Biology Networks and Key Gene Regulators for Inflammatory Biomarkers Shared by Breast Cancer Development: Multi-Omics Systems Analysis.
- Author
-
Jung, Su Yon, Papp, Jeanette C., Pellegrini, Matteo, Yu, Herbert, and Sobel, Eric M.
- Subjects
- *
MOLECULAR biology , *REGULATOR genes , *CARCINOGENESIS , *BIOMARKERS , *GENOME-wide association studies , *GENE regulatory networks - Abstract
As key inflammatory biomarkers C-reactive protein (CRP) and interleukin-6 (IL6) play an important role in the pathogenesis of non-inflammatory diseases, including specific cancers, such as breast cancer (BC). Previous genome-wide association studies (GWASs) have neither explained the large proportion of genetic heritability nor provided comprehensive understanding of the underlying regulatory mechanisms. We adopted an integrative genomic network approach by incorporating our previous GWAS data for CRP and IL6 with multi-omics datasets, such as whole-blood expression quantitative loci, molecular biologic pathways, and gene regulatory networks to capture the full range of genetic functionalities associated with CRP/IL6 and tissue-specific key drivers (KDs) in gene subnetworks. We applied another systematic genomics approach for BC development to detect shared gene sets in enriched subnetworks across BC and CRP/IL6. We detected the topmost significant common pathways across CRP/IL6 (e.g., immune regulatory; chemokines and their receptors; interferon γ, JAK-STAT, and ERBB4 signaling), several of which overlapped with BC pathways. Further, in gene–gene interaction networks enriched by those topmost pathways, we identified KDs—both well-established (e.g., JAK1/2/3, STAT3) and novel (e.g., CXCR3, CD3D, CD3G, STAT6)—in a tissue-specific manner, for mechanisms shared in regulating CRP/IL6 and BC risk. Our study may provide robust, comprehensive insights into the mechanisms of CRP/IL6 regulation and highlight potential novel genetic targets as preventive and therapeutic strategies for associated disorders, such as BC. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
35. Multi-Omics Data Analysis Uncovers Molecular Networks and Gene Regulators for Metabolic Biomarkers.
- Author
-
Jung, Su Yon and Joven, Jorge
- Subjects
- *
REGULATOR genes , *SOMATOMEDIN , *LOCUS (Genetics) , *GENE regulatory networks , *BIOMARKERS , *PHENOTYPIC plasticity , *DATA analysis - Abstract
The insulin-like growth factors (IGFs)/insulin resistance (IR) axis is the major metabolic hormonal pathway mediating the biologic mechanism of several complex human diseases, including type 2 diabetes (T2DM) and cancers. The genomewide association study (GWAS)-based approach has neither fully characterized the phenotype variation nor provided a comprehensive understanding of the regulatory biologic mechanisms. We applied systematic genomics to integrate our previous GWAS data for IGF-I and IR with multi-omics datasets, e.g., whole-blood expression quantitative loci, molecular pathways, and gene network, to capture the full range of genetic functionalities associated with IGF-I/IR and key drivers (KDs) in gene-regulatory networks. We identified both shared (e.g., T2DM, lipid metabolism, and estimated glomerular filtration signaling) and IR-specific (e.g., mechanistic target of rapamycin, phosphoinositide 3-kinases, and erb-b2 receptor tyrosine kinase 4 signaling) molecular biologic processes of IGF-I/IR axis regulation. Next, by using tissue-specific gene–gene interaction networks, we identified both well-established (e.g., IRS1 and IGF1R) and novel (e.g., AKT1, HRAS, and JAK1) KDs in the IGF-I/IR-associated subnetworks. Our results, if validated in additional genomic studies, may provide robust, comprehensive insights into the mechanisms of IGF-I/IR regulation and highlight potential novel genetic targets as preventive and therapeutic strategies for the associated diseases, e.g., T2DM and cancers. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
36. Raw Garlic Consumption and Risk of Liver Cancer: A Population-Based Case-Control Study in Eastern China.
- Author
-
Liu, Xing, Baecker, Aileen, Wu, Ming, Zhou, Jin-Yi, Yang, Jie, Han, Ren-Qiang, Wang, Pei-Hua, Liu, Ai-Min, Gu, Xiaoping, Zhang, Xiao-Feng, Wang, Xu-Shan, Su, Ming, Hu, Xu, Sun, Zheng, Li, Gang, Jin, Zi-Yi, Jung, Su Yon, Mu, Lina, He, Na, and Lu, Qing-Yi
- Abstract
Although the major risk factors for liver cancer have been established, preventive factors for liver cancer have not been fully explored. We evaluated the association between raw garlic consumption and liver cancer in a large population-based case-control study in Eastern China. The study was conducted in Jiangsu, China, from 2003 to 2010. A total of 2011 incident liver cancer cases and 7933 randomly selected population-controls were interviewed. Epidemiological data including raw garlic intake and other exposures were collected, and serum markers of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection were assayed. Overall, eating raw garlic twice or more per week was inversely associated with liver cancer, with an adjusted odds ratio (aOR) of 0.77 (95% confidence interval (CI): 0.62–0.96) compared to those ingesting no raw garlic or less than twice per week. In stratified analyses, high intake of raw garlic was inversely associated with liver cancer among Hepatitis B surface antigen (HBsAg) negative individuals, frequent alcohol drinkers, those having history of eating mold-contaminated food or drinking raw water, and those without family history of liver cancer. Marginal interactions on an additive scale were observed between low raw garlic intake and HBsAg positivity (attributable proportion due to interaction (AP) = 0.31, 95% CI: -0.01–0.62) and heavy alcohol drinking (AP = 0.28, 95% CI: 0.00–0.57). Raw garlic consumption is inversely associated with liver cancer. Such an association shed some light on the potential etiologic role of garlic intake on liver cancer, which in turn might provide a possible dietary intervention to reduce liver cancer in Chinese population. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
37. Estrogen Plus Progestin and Colorectal Cancer: Long-Term Findings From the Women's Health Initiative Randomized Clinical Trial.
- Author
-
Chlebowski RT, Aragaki AK, Pan K, Luo J, Rohan TE, Johnson KC, Wactawski-Wende J, Jung SY, Xiao Q, Lavasani S, Manson JE, and Simon MS
- Subjects
- Humans, Female, Middle Aged, Aged, Postmenopause, Women's Health, Estrogen Replacement Therapy adverse effects, Colorectal Neoplasms mortality, Colorectal Neoplasms drug therapy, Medroxyprogesterone Acetate administration & dosage, Medroxyprogesterone Acetate adverse effects, Estrogens, Conjugated (USP) administration & dosage, Estrogens, Conjugated (USP) adverse effects, Estrogens, Conjugated (USP) therapeutic use
- Abstract
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been reported. We report long-term colorectal cancer findings from the Women's Health Initiative trial where 16,608 postmenopausal women with a uterus were randomly assigned to daily conjugated equine estrogen (CEE) 0.625 mg, plus medroxyprogesterone acetate (MPA) 2.5 mg, or placebo. When intervention ended after 5.6 years, although there were 44% fewer colorectal cancers in the intervention group (43 v 72, P = .003), the cancers were more commonly lymph node-positive (59.0% v 29.4%, P = .003). Now after cumulative 24-year follow-up, with 431 colorectal cancers, CEE plus MPA no longer influenced colorectal cancer incidence (215 [0.15, annualized rate %] v 216 [0.15], hazard ratio [HR], 0.95 [95% CI, 0.79 to 1.15]). Although not statistically significant, there were more colorectal cancer deaths with CEE plus MPA (87 [0.049] v 69 [0.041] deaths, HR, 1.20 [95% CI, 0.87 to 1.65], P = .26). Vaginal bleeding (54.1% v 5.2% at 6 months) and breast changes were more frequent in the intervention group. After adjusting for postrandomization vaginal bleeding and breast changes, bowel examinations were significantly delayed in intervention group participants ( P = .005), potentially contributing to diagnostic delay. Taken together, the findings suggest no clinically meaningful benefit for about 5 years of CEE plus MPA use on colorectal cancer outcome.
- Published
- 2024
- Full Text
- View/download PDF
38. Low physical function following cancer diagnosis is associated with higher mortality risk in postmenopausal women.
- Author
-
Gonzalo-Encabo P, Vasbinder A, Bea JW, Reding KW, Laddu D, LaMonte MJ, Stefanick ML, Kroenke CH, Jung SY, Shadyab AH, Naughton MJ, Patel MI, Luo J, Banack HR, Sun Y, Simon MS, and Dieli-Conwright CM
- Subjects
- Humans, Female, Aged, Prospective Studies, Middle Aged, Cause of Death, Risk Factors, Physical Functional Performance, Follow-Up Studies, Postmenopause, Neoplasms mortality, Neoplasms diagnosis
- Abstract
Background: Postmenopausal women with cancer experience an accelerated physical dysfunction beyond what is expected through aging alone due to cancer and its treatments. The aim of this study was to determine whether declines in physical function after cancer diagnosis are associated with all-cause mortality and cancer-specific mortality., Methods: This prospective cohort study included 8068 postmenopausal women enrolled in the Women's Health Initiative with a cancer diagnosis and who had physical function assessed within 1 year of that diagnosis. Self-reported physical function was measured using the 10-item physical function subscale of the 36-Item Short Form Health Survey. Cause of death was determined by medical record review, with central adjudication and linkage to the National Death Index. Death was adjudicated through February 2022., Results: Over a median follow-up of 7.7 years from cancer diagnosis, 3316 (41.1%) women died. Our results showed that for every 10% difference in the physical function score after cancer diagnosis versus pre-diagnosis, all-cause mortality and cancer-specific mortality were reduced by 12% (hazard ratio [HR] = 0.88, 95% confidence interval [95% CI] = 0.87 to 0.89 and HR = 0.88, 95% CI = 0.86 to 0.91, respectively). Further categorical analyses showed a significant dose-response relationship between postdiagnosis physical function categories and mortality outcomes (P < .001 for trend), where the median survival time for women in the lowest physical function quartile was 9.1 years (Interquartile range [IQR] = 8.6-10.6 years) compared with 18.4 years (IQR = 15.8-22.0 years) for women in the highest physical function quartile., Conclusion: Postmenopausal women with low physical function after cancer diagnosis may be at higher risk of mortality from all causes and cancer-related mortality., (© The Author(s) 2024. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.)
- Published
- 2024
- Full Text
- View/download PDF
39. Relationships of depression and antidepressant use with epigenetic age acceleration and all-cause mortality among postmenopausal women.
- Author
-
Beydoun MA, Beydoun HA, Ashe J, Georgescu MF, Horvath S, Lu A, Zannas AS, Shadyab AH, Jung SY, Wassertheil-Smoller S, Casanova R, Zonderman AB, and Brunner RL
- Subjects
- Humans, Female, Middle Aged, Aged, Aging genetics, Mortality, Antidepressive Agents therapeutic use, Depression genetics, Depression drug therapy, Postmenopause, Epigenesis, Genetic, DNA Methylation
- Abstract
We investigated relations of depressive symptoms, antidepressant use, and epigenetic age acceleration with all-cause mortality risk among postmenopausal women. Data were analyzed from ≤1,900 participants in the Women's Health Initiative study testing four-way decomposition models. After a median 20.4y follow-up, 1,161 deaths occurred. Approximately 11% had elevated depressive symptoms (EDS
+ ), 7% were taking antidepressant medication at baseline (ANTIDEP+ ), while 16.5% fell into either category (EDS_ANTIDEP+ ). Baseline ANTIDEP+ , longitudinal transition into ANTIDEP+ and accelerated epigenetic aging directly predicted increased mortality risk. GrimAge DNA methylation age acceleration (AgeAccelGrim) partially mediated total effects of baseline ANTIDEP+ and EDS_ANTIDEP+ on all-cause mortality risk in socio-demographic factors-adjusted models (Pure Indirect Effect >0, P < 0.05; Total Effect >0, P < 0.05). Thus, higher AgeAccelGrim partially explained the relationship between antidepressant use and increased all-cause mortality risk, though only prior to controlling for lifestyle and health-related factors. Antidepressant use and epigenetic age acceleration independently predicted increased all-cause mortality risk. Further studies are needed in varying populations.- Published
- 2024
- Full Text
- View/download PDF
40. Novel DNA methylation-based epigenetic signatures in colorectal cancer from peripheral blood leukocytes.
- Author
-
Jung SY, Yu H, Tan X, and Pellegrini M
- Abstract
Colorectal cancer (CRC) is a multifactorial disease characterized by accumulation of multiple genetic and epigenetic alterations, transforming colonic epithelial cells into adenocarcinomas. Alteration of DNA methylation (DNAm) is a promising biomarker for predicting cancer risk and prognosis, but its role in CRC tumorigenesis is inconclusive. Notably, few DNAm studies have used pre-diagnostic peripheral blood (PB) DNA, causing difficulty in postulating the underlying biologic mechanism of CRC initiation. We conducted epigenome-wide association (EWA) scans in postmenopausal women from Women's Health Initiative (WHI) with their pre-diagnostic DNAm in PB leukocytes (PBLs) to prospectively evaluate CRC development. Our site-specific DNAm analyses across the genome adjusted for DNAm-age, leukocyte heterogeneities, as well as body mass index, diabetes, and insulin resistance. We validated 20 top EWA-CpGs in 2 independent CRC tissue datasets. Also, we detected differentially methylated regions (DMRs) associated with CRC, further mapped to transcriptomic profile, and finally conducted a Gene Set Enrichment Analysis. We detected multiple novel CpGs validated across WHI and tissue datasets. In particular, 2 CpGs ( B4GALNT4 cg10321339, SV2B cg18144285) had the strongest effect on CRC risk. Results from our DMR scans contained MIR663 cg06007966, which was also validated in EWA analyses. Also, we detected 1 methylome region in PEG10 of Chr7 shared across datasets. Our findings reflect both novel and well-established epigenomic and transcriptomic sites in CRC, warranting further functional validations. Our study contributes to better understanding of the complex interrelated mechanisms on the methylome underlying CRC tumorigenesis and suggests novel preventive DNAm-targets in PBLs for detecting at-risk individuals for CRC development., Competing Interests: None., (AJCR Copyright © 2024.)
- Published
- 2024
- Full Text
- View/download PDF
41. Bilateral Oophorectomy and Colorectal Cancer Incidence and Mortality in the Women's Health Initiative.
- Author
-
Song M, Nelson RA, Kruper L, Mortimer J, Luo J, Jung SY, Wallace RB, and Chlebowski R
- Subjects
- Female, Humans, Incidence, Cohort Studies, Ovariectomy adverse effects, Risk Factors, Women's Health, Colorectal Neoplasms epidemiology
- Abstract
Background: The few cohort studies examining oophorectomy and colorectal cancer risk provide mixed results. Therefore, we examined this issue in Women's Health Initiative Observational Study participants., Methods: A total of 71,312 postmenopausal women were followed for 22.1 years (median). At enrollment, 55,643 (78%) had intact ovaries and 15,669 (22%) had undergone a bilateral oophorectomy. Colorectal cancers were verified by central medical record review with mortality findings enhanced by National Death Index queries., Results: With 1,421 incident colorectal cancers, 450 colorectal cancer-specific mortalities, after controlling for covariates, bilateral oophorectomy was not associated with colorectal cancer incidence or colorectal cancer mortality., Conclusions: No significant associations between oophorectomy and colorectal cancer incidence and mortality were seen in a large cohort study with long follow-up., Impact: As the oophorectomy and colorectal cancer question remains open, further studies of high quality, even with null findings, should be encouraged., (©2023 American Association for Cancer Research.)
- Published
- 2023
- Full Text
- View/download PDF
42. Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trials.
- Author
-
Peila R, Xue X, LaMonte MJ, Shadyab AH, Wactawski-Wende J, Jung SY, Johnson KC, Coday M, Richey P, Mouton CP, Saquib N, Chlebowski RT, Pan K, Michael YL, LeBoff MS, Manson JE, and Rohan TE
- Subjects
- Female, Humans, Women's Health, Menopause, Exercise, Estrogen Replacement Therapy, Medroxyprogesterone Acetate, Estrogens, Conjugated (USP), Estrogens
- Abstract
Objective: The menopausal transition results in a progressive decrease in circulating estrogen levels. Experimental evidence in rodents has indicated that estrogen depletion leads to a reduction of energy expenditure and physical activity. It is unclear whether treatment with estrogen therapy increases physical activity level in postmenopausal women., Methods: A total of 27,327 postmenopausal women aged 50-79 years enrolled in the Women's Health Initiative randomized double-blind trials of menopausal hormone therapy. Self-reported leisure-time physical activity at baseline, and years 1, 3, and 6 was quantified as metabolic equivalents (MET)-h/wk. In each trial, comparison between intervention and placebo groups of changes in physical activity levels from baseline to follow-up assessment was examined using linear regression models., Results: In the CEE-alone trial, the increase in MET-h/wk was greater in the placebo group compared with the intervention group at years 3 ( P = 0.002) and 6 ( P < 0.001). Similar results were observed when analyses were restricted to women who maintained an adherence rate ≥80% during the trial or who were physically active at baseline. In the CEE + MPA trial, the primary analyses did not show significant differences between groups, but the increase of MET-h/wk was greater in the placebo group compared with the intervention group at year 3 ( P = 0.004) among women with an adherence rate ≥80%., Conclusions: The results from this clinical trial do not support the hypothesis that estrogen treatment increases physical activity among postmenopausal women., Competing Interests: Conflict of interest/financial disclosures: R.T.C. receives ongoing funding from UpToDate . M.S.L. received $1000 honorarium from the New England Bone Club for a plenary lecture at the 2022 New England Bone Club meeting. The other authors have nothing to disclose., (Copyright © 2023 by The North American Menopause Society.)
- Published
- 2023
- Full Text
- View/download PDF
43. Estimating heritability explained by local ancestry and evaluating stratification bias in admixture mapping from summary statistics.
- Author
-
Chan TF, Rui X, Conti DV, Fornage M, Graff M, Haessler J, Haiman C, Highland HM, Jung SY, Kenny E, Kooperberg C, Marchland LL, North KE, Tao R, Wojcik G, Gignoux CR, Chiang CWK, and Mancuso N
- Abstract
The heritability explained by local ancestry markers in an admixed population h γ 2 provides crucial insight into the genetic architecture of a complex disease or trait. Estimation of h γ 2 can be susceptible to biases due to population structure in ancestral populations. Here, we present a novel approach, Heritability estimation from Admixture Mapping Summary STAtistics (HAMSTA), which uses summary statistics from admixture mapping to infer heritability explained by local ancestry while adjusting for biases due to ancestral stratification. Through extensive simulations, we demonstrate that HAMSTA h γ 2 estimates are approximately unbiased and are robust to ancestral stratification compared to existing approaches. In the presence of ancestral stratification, we show a HAMSTA-derived sampling scheme provides a calibrated family-wise error rate (FWER) of ~5% for admixture mapping, unlike existing FWER estimation approaches. We apply HAMSTA to 20 quantitative phenotypes of up to 15,988 self-reported African American individuals in the Population Architecture using Genomics and Epidemiology (PAGE) study. We observe h ˆ γ 2 in the 20 phenotypes range from 0.0025 to 0.033 (mean h ˆ γ 2 = 0.012 + / - 9.2 × 10 - 4 ), which translates to h ˆ 2 ranging from 0.062 to 0.85 (mean h ˆ 2 = 0.30 + / - 0.023 ). Across these phenotypes we find little evidence of inflation due to ancestral population stratification in current admixture mapping studies (mean inflation factor of 0.99 +/- 0.001). Overall, HAMSTA provides a fast and powerful approach to estimate genome-wide heritability and evaluate biases in test statistics of admixture mapping studies.
- Published
- 2023
- Full Text
- View/download PDF
44. Genetic variants of glucose metabolism and exposure to smoking in African American breast cancer.
- Author
-
Jung SY, Papp JC, Sobel EM, Pellegrini M, and Yu H
- Subjects
- Female, Humans, Genetic Predisposition to Disease, Genome-Wide Association Study, Black or African American genetics, Smoking, Risk Factors, Glucose, Polymorphism, Single Nucleotide, Breast Neoplasms epidemiology, Breast Neoplasms genetics, Insulin Resistance genetics
- Abstract
Insulin resistance (IR) is a well-established risk factor for breast cancer (BC) development in African American (AA) postmenopausal women. While obesity and IR are more prevalent in AA than in white women, they are under-represented in genome-wide studies for systemic regulation of IR. By examining 780 genome-wide IR single-nucleotide polymorphisms (SNPs) available in our data, we tested 4689 AA women in a Random Survival Forest framework. With 37 BC-associated lifestyle factors, we conducted a gene-environment interaction analysis to estimate risk prediction for BC with the most influential genetic and behavioral factors and evaluated their combined and joint effects on BC risk. By accounting for variations of individual SNPs in BC in the prediction model, we detected four fasting glucose-associated SNPs in PCSK1, SPC25, ADCY5, and MTNR1B and three lifestyle factors (smoking, oral contraceptive use, and age at menopause) as the most predictive markers for BC risk. Our joint analysis of risk genotypes and lifestyle with smoking revealed a synergistic effect on the increased risk of BC, particularly estrogen/progesterone positive (ER/PR+) BC, in a gene-lifestyle dose-dependent manner. The joint effect of smoking was more substantial in women with prolonged exposure to cigarette smoking and female hormones. The top genome-wide association-SNPs associated with metabolic biomarkers in combination with lifestyles synergistically increase the predictability of invasive ER/PR+ BC risk among AA women. Our findings highlight generically targeted preventive interventions for women who carry particular risk genotypes and lifestyles.
- Published
- 2023
- Full Text
- View/download PDF
45. DNA methylation patterns associated with breast cancer prognosis that are specific to tumor subtype and menopausal status.
- Author
-
Kim DH, Binder AM, Zhou H, and Jung SY
- Abstract
Tumor subtype and menopausal status are strong predictors of breast cancer (BC) prognosis. We aimed to find and validate subtype- or menopausal-status-specific changes in tumor DNA methylation (DNAm) associated with all-cause mortality or BC progression. Associations between site-specific tumor DNAm and BC prognosis were estimated among The Cancer Genome Atlas participants ( n = 692) with Illumina Infinium HumanMethylation450 BeadChip array data. All-cause mortality and BC progression were modeled using Cox proportional hazards models stratified by tumor subtypes, adjusting for age, race, stage, menopausal status, tumor purity, and cell type proportion. Effect measure modification by subtype and menopausal status were evaluated by incorporating a product term with DNAm. Site-specific inference was used to identify subtype- or menopausal-status-specific differentially methylated regions (DMRs) and functional pathways. The validation of the results was carried out on an independent dataset (GSE72308; n = 180). We identified a total of fifteen unique CpG probes that were significantly associated ( P ≤ 1 × 10 - 7 with survival outcomes in subtype- or menopausal-status-specific manner. Seven probes were associated with overall survival (OS) or progression-free interval (PFI) for women with luminal A subtype, and four probes were associated with PFI for women with luminal B subtype. Five probes were associated with PFI for post-menopausal women. A majority of significant probes showed a lower risk of OS or BC progression with higher DNAm. We identified subtype- or menopausal-status-specific DMRs and functional pathways of which top associated pathways differed across subtypes or menopausal status. None of significant probes from site-specific analyses met genome-wide significant level in validation analyses while directions and magnitudes of coefficients showed consistent pattern. We have identified subtype- or menopausal-status-specific DNAm biomarkers, DMRs and functional pathways associated with all-cause mortality or BC progression, albeit with limited validation. Future studies with larger independent cohort of non-post-menopausal women with non-luminal A subtypes are warranted for identifying subtype- and menopausal-status-specific DNAm biomarkers for BC prognosis., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2023 Kim, Binder, Zhou and Jung.)
- Published
- 2023
- Full Text
- View/download PDF
46. Genetically determined elevated C-reactive protein associated with primary colorectal cancer risk: Mendelian randomization with lifestyle interactions.
- Author
-
Jung SY, Yu H, Pellegrini M, Papp JC, Sobel EM, and Zhang ZF
- Abstract
Systemic inflammation-related etiologic pathways via inflammatory cytokines in the development of colorectal cancer (CRC) have not been convincingly determined and may be confounded by lifestyle factors or reverse causality. We investigated the genetically predicted C-reactive protein (CRP) phenotype in the potential causal pathway of primary CRC risk in postmenopausal women in a Mendelian randomization (MR) framework. We employed individual-level data of the Women's Health Initiative Database for Genotypes and Phenotypes Study, which consists of 5 genome-wide association (GWA) studies, including 10,142 women, 737 of whom developed primary CRC. We examined 61 GWA single-nucleotide polymorphisms (SNPs) associated with CRP by using weighted/penalized MR weighted-medians and MR gene-environment interactions that allow some relaxation of the strict variable requirements and attenuate the heterogeneous estimates of outlying SNPs. In lifestyle-stratification analyses, genetically determined CRP exhibited its effects on the decreased CRC risk in non-viscerally obese and high-fat diet subgroups. In contrast, genetically driven CRP was associated with an increased risk for CRC in women who smoked ≥ 15 cigarettes/day, with significant interaction of the gene-smoking relationship. Further, a substantially increased risk of CRC induced by CRP was observed in relatively short-term users (< 5 years) of estrogen (E)-only and also longer-term users (5 to > 10 years) of E plus progestin. Our findings may provide novel evidence on immune-related etiologic pathways connected to CRC risk and suggest the possible use of CRP as a CRC-predictive biomarker in women with particular behaviors and CRP marker-informed interventions to reduce CRC risk., Competing Interests: None., (AJCR Copyright © 2021.)
- Published
- 2021
47. Genome-wide Association Analysis of Proinflammatory Cytokines and Gene-lifestyle Interaction for Invasive Breast Cancer Risk: The WHI dbGaP Study.
- Author
-
Jung SY, Scott PA, Papp JC, Sobel EM, Pellegrini M, Yu H, Han S, and Zhang ZF
- Subjects
- Aged, Biomarkers, Tumor metabolism, Breast Neoplasms genetics, Breast Neoplasms immunology, Cytokines metabolism, Female, Follow-Up Studies, Genetic Predisposition to Disease, Genome-Wide Association Study, Humans, Life Style, Middle Aged, Obesity immunology, Obesity metabolism, Polymorphism, Single Nucleotide, Postmenopause, Risk Factors, Signal Transduction immunology, Biomarkers, Tumor genetics, Breast Neoplasms epidemiology, Cytokines genetics, Gene-Environment Interaction, Obesity epidemiology
- Abstract
Immune-related etiologic pathways to influence invasive breast cancer risk may interact with lifestyle factors, but the interrelated molecular genetic pathways are incompletely characterized. We used data from the Women's Health Initiative Database for Genotypes and Phenotypes Study including 16,088 postmenopausal women, a population highly susceptible to inflammation, obesity, and increased risk for breast cancer. With 21,784,812 common autosomal single-nucleotide polymorphisms (SNP), we conducted a genome-wide association (GWA) gene-environment interaction (G × E) analysis in six independent GWA Studies for proinflammatory cytokines [IL6 and C-reactive protein (CRP)] and their gene-lifestyle interactions. Subsequently, we tested for the association of the GWA SNPs with breast cancer risk. In women overall and stratified by obesity status (body mass index, waist circumference, and waist-to-hip ratio) and obesity-related lifestyle factors (exercise and high-fat diet), 88 GWA SNPs in 10 loci were associated with proinflammatory cytokines: 3 associated with IL6 (1 index SNP in MAPK1 and 1 independent SNP in DEC1 ); 85 with CRP (3 index SNPs in CRPP1, CRP, RP11-419N10.5, HNF1A-AS1, HNF1A , and C1q2orf43 ; and two independent SNPs in APOE and APOC1 ). Of those, 27 in HNF1A-AS1, HNF1A , and C1q2orf43 displayed significantly increased risk for breast cancer. We found a number of novel top markers for CRP and IL6, which interacted with obesity factors. A substantial proportion of those SNPs' susceptibility influenced breast cancer risk. Our findings may contribute to better understanding of genetic associations between pro-inflammation and cancer and suggest intervention strategies for women who carry the risk genotypes, reducing breast cancer risk. PREVENTION RELEVANCE: The top GWA-SNPs associated with pro-inflammatory biomarkers have implications for breast carcinogenesis by interacting with obesity factors. Our findings may suggest interventions for women who carry the inflammatory-risk genotypes to reduce breast cancer risk., (©2020 American Association for Cancer Research.)
- Published
- 2021
- Full Text
- View/download PDF
48. Pro-inflammatory cytokine polymorphisms in ONECUT2 and HNF4A and primary colorectal carcinoma: a post genome-wide gene-lifestyle interaction study.
- Author
-
Jung SY, Papp JC, Sobel EM, Pellegrini M, Yu H, and Zhang ZF
- Abstract
Immune-related molecular and genetic pathways that are connected to colorectal cancer (CRC) and lifestyles in postmenopausal women are incompletely characterized. In this study, we examined the role of pro-inflammatory biomarkers such as C-reactive protein (CRP) and interleukin-6 (IL-6) in those pathways. Through selection of the best predictive single-nucleotide polymorphisms (SNPs) and lifestyles, our goal was to improve the prediction accuracy and ability for CRC risk. Using large cohort data of postmenopausal women from the Women's Health Initiative Database for Genotypes and Phenotypes Study, we previously conducted a genome-wide association (GWA) for a CRP and IL-6 gene-behavioral interaction study. For the present study, we added GWA-SNPs from outside GWA studies, resulting in a total of 152 SNPs. Together with 41 selected lifestyles, we performed a 2-stage multimodal random survival forest analysis with generalized multifactor dimensionality reduction approach to construct CRC risk profiles. Overall and in obesity strata (by body mass index, waist circumference, waist-to-hip ratio, exercise, and dietary fat intake), we identified the best predictive genetic markers in inflammatory cytokines and lifestyles. Across the strata, 2 SNPs ( ONECUT2 rs4092465 and HNF4A rs1800961) and 1 lifestyle factor (relatively short-term past use of oral contraceptives) were the most common and strongest predictive markers for CRC risk. The risk profile that combined those variables exhibited synergistically increased risk for CRC; this pattern appeared more strongly in obese and inactive subgroups. Our results may contribute to improved predictability for CRC and suggest genetically targeted lifestyle interventions for women carrying the inflammatory-risk genotypes, reducing CRC risk., Competing Interests: None., (AJCR Copyright © 2020.)
- Published
- 2020
49. Mendelian Randomization Study: The Association Between Metabolic Pathways and Colorectal Cancer Risk.
- Author
-
Jung SY, Papp JC, Sobel EM, and Zhang ZF
- Abstract
Background: The roles of obesity-related biomarkers and their molecular pathways in the development of postmenopausal colorectal cancer (CRC) have been inconclusive. We examined insulin resistance (IR) as a major hormonal pathway mediating the association between obesity and CRC risk in a Mendelian randomization (MR) framework. Methods: We performed MR analysis using individual-level data of 11,078 non-Hispanic white postmenopausal women from our earlier genome-wide association study. We identified four independent single-nucleotide polymorphisms associated with fasting glucose (FG), three with fasting insulin (FI), and six with homeostatic model assessment-IR (HOMA-IR), which were not associated with obesity. We estimated hazard ratios (HRs) for CRC by adjusting for potential confounding factors plus genetic principal components. Results: Overall, we observed no direct association between combined 13 IR genetic instruments and CRC risk (HR = 0.96, 95% confidence interval [CI]: 0.78-1.17). In phenotypic analysis, genetically raised HOMA-IR exhibited its effects on the increased risk and FG and FI on the reduced risk for CRC, but with a lack of statistical power. Subgroup analyses by physical activity level and dietary fat intake with combined phenotypes showed that genetically determined IR was associated with reduced CRC risk in both physical activity-stratified (single contributor: MTRR rs722025; HR = 0.12, 95% CI: 0.02-0.62) and high-fat diet subgroups (main contributor: G6PC2 rs560887; HR = 0.59, 95% CI: 0.37-0.94). Conclusions: Complex evidence was observed for a potential causal association between IR and CRC risk. Our findings may provide an additional value of intervention trials to lower IR and reduce CRC risk., (Copyright © 2020 Jung, Papp, Sobel and Zhang.)
- Published
- 2020
- Full Text
- View/download PDF
50. Post Genome-Wide Gene-Environment Interaction Study Using Random Survival Forest: Insulin Resistance, Lifestyle Factors, and Colorectal Cancer Risk.
- Author
-
Jung SY, Papp JC, Sobel EM, and Zhang ZF
- Subjects
- Aged, Aged, 80 and over, Colorectal Neoplasms genetics, Colorectal Neoplasms prevention & control, Female, Ferredoxin-NADP Reductase genetics, Genome-Wide Association Study, Humans, Middle Aged, Polymorphism, Single Nucleotide, Postmenopause, RNA, Long Noncoding genetics, Risk Factors, Colorectal Neoplasms epidemiology, Gene-Environment Interaction, Genetic Predisposition to Disease, Insulin Resistance genetics, Life Style
- Abstract
Molecular and genetic pathways of insulin resistance (IR) connecting colorectal cancer and obesity factors in postmenopausal women remain inconclusive. We examined the IR pathways on both genetic and phenotypic perspectives at the genome-wide level. We further constructed colorectal cancer risk profiles with the most predictive IR SNPs and lifestyle factors. In our earlier genome-wide association gene-environmental interaction study, we used data from a large cohort of postmenopausal women in the Women's Health Initiative Database for Genotypes and Phenotypes Study and identified 58 SNPs in relation to IR phenotypes. In this study, we evaluated the identified IR SNPs and selected 34 lifestyles for their association with colorectal cancer risk in a total of 11,078 women (including 736 women with colorectal cancer) using a 2-stage multimodal random survival forest analysis. In overall and subgroup (defined via body mass index, exercise, and dietary-fat intake) analyses, we identified 2 SNPs ( LINC00460 rs1725459 and MTRR rs722025) and lifetime cumulative exposure to estrogen (oral contraceptive use) and cigarette smoking as the most common and strongest predictive markers for colorectal cancer risk across the analyses. The combinations of genetic and lifestyle factors had much greater impact on colorectal cancer risk than any individual risk factors, and a possible synergism existed to increase colorectal cancer risk in a gene-behavior dose-dependent manner. Our findings may inform research on the role of IR in the etiology of colorectal cancer and contribute to more accurate prediction of colorectal cancer risk, suggesting potential intervention strategies for women with specific genotypes and lifestyles to reduce their colorectal cancer risk., (©2019 American Association for Cancer Research.)
- Published
- 2019
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.